M

Microba Life Sciences Ltd
ASX:MAP

Watchlist Manager
Microba Life Sciences Ltd
ASX:MAP
Watchlist
Price: 0.195 AUD 5.41% Market Closed
Market Cap: 87.3m AUD
Have any thoughts about
Microba Life Sciences Ltd?
Write Note

Wall Street
Price Targets

MAP Price Targets Summary
Microba Life Sciences Ltd

Wall Street analysts forecast MAP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAP is 0.381 AUD with a low forecast of 0.333 AUD and a high forecast of 0.462 AUD.

Lowest
Price Target
0.333 AUD
71% Upside
Average
Price Target
0.381 AUD
95% Upside
Highest
Price Target
0.462 AUD
137% Upside
Microba Life Sciences Ltd Competitors:
Price Targets
ACL
Australian Clinical Labs Ltd
2% Upside
1951
Jinxin Fertility Group Ltd
48% Upside
LH
Laboratory Corporation of America Holdings
17% Upside
603882
Guangzhou Kingmed Diagnostics Group Co Ltd
18% Upside
IDHC
Integrated Diagnostics Holdings PLC
26% Upside
VOX
Voxel SA
22% Downside

Revenue
Forecast

Revenue Estimate
Microba Life Sciences Ltd

For the last 4 years the compound annual growth rate for Microba Life Sciences Ltd's revenue is 43%. The projected CAGR for the next 3 years is 51%.

43%
Past Growth
51%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Microba Life Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
21%
Average Beat

Net Income
Forecast

Net Income Estimate
Microba Life Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MAP's stock price target?
Price Target
0.381 AUD

According to Wall Street analysts, the average 1-year price target for MAP is 0.381 AUD with a low forecast of 0.333 AUD and a high forecast of 0.462 AUD.

What is Microba Life Sciences Ltd's Revenue forecast?
Projected CAGR
51%

For the last 4 years the compound annual growth rate for Microba Life Sciences Ltd's revenue is 43%. The projected CAGR for the next 3 years is 51%.

Back to Top